The first treatment for a rare disease characterised by high levels of triglycerides in blood is among eight new medicines put forward by the European Medicines Agency'a human medicines committee (CHMP) for approval.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.